Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01431469
Other study ID # 6001
Secondary ID
Status Completed
Phase N/A
First received August 31, 2011
Last updated December 5, 2012
Start date September 2011
Est. completion date May 2012

Study information

Verified date December 2012
Source Mead Johnson Nutrition
Contact n/a
Is FDA regulated No
Health authority Brazil: HUPES Complex Ethics Committee (CEP)
Study type Interventional

Clinical Trial Summary

The purpose is to determine if the consumption of study product has an effect on acute respiratory infections and/or diarrheal disease.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 12 Months to 48 Months
Eligibility Inclusion Criteria:

- Child 12-48 months of age

- Has consumed cow's milk or a cow's milk-based beverage during the 48 hours prior to randomization

- Signed informed consent

Exclusion Criteria:

- Child who is receiving predominantly breast-milk

- Child who received any food product or supplement containing probiotics or prebiotics in the 15 days prior to randomization

- Child with allergy to gluten or serious concurrent illness that will interfere in the general management of the child

- Child with diarrhea or acute respiratory infection during the 48 hours prior to randomization

- Child's z-score of weight for length/height < -3 according to World Health Organization criteria

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Dietary Supplement:
Cow's milk
Powdered Whole Cow's Milk
Follow-On Formula
Powdered Follow-On Formula with added long-chain Polyunsaturated fatty acid, prebiotics, and polysaccharide

Locations

Country Name City State
Brazil Universidade Federal da Bahia, Hospital Universitário Prof. Edgard Santos Complexo HUPES, Centro Pediátrico Professor Hossanah Oliveira, Centro da Pesquisas Fima Lifshitz, Rua Augusto Viana s/n Canela Salvador Bahia

Sponsors (2)

Lead Sponsor Collaborator
Mead Johnson Nutrition Federal University of Bahia

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Episodes of acute respiratory infections and diarrheal disease 28 weeks No
Secondary Occurrence of allergic manifestations 28 weeks No
Secondary Systemic antibiotic use 28 weeks No
Secondary Duration of acute respiratory infection and diarrheal disease 28 weeks No
Secondary Changes in stool patterns 28 weeks No
Secondary Fecal and serum immune markers 28 weeks No
Secondary Serum Ferritin and Zinc status 28 weeks No
Secondary Incidence of stool parasites 28 weeks No
Secondary Growth 28 weeks No
Secondary Incidence of adverse events The incidence of any adverse event for each participant 28 weeks No
Secondary Acceptance of study product Acceptance of study product based on quantity consumed 28 weeks No
See also
  Status Clinical Trial Phase
Completed NCT03943654 - Improving Nighttime Access to Care and Treatment (Part 2)
Completed NCT05269290 - Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections Phase 3
Completed NCT06385821 - A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus Phase 3
Not yet recruiting NCT05902702 - Isotonic Saline for Children With Bronchiolitis N/A
Not yet recruiting NCT04525118 - Wide Scale Monitoring for Acute Respiratory Infection Using a Mobile-based Study Platform
Completed NCT00981513 - Direct and Indirect Benefits of Influenza Vaccination in Schools and Households Phase 4
Recruiting NCT06183229 - Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza Phase 3
Completed NCT03274310 - FluSAFE: Flu SMS Alerts to Freeze Exposure N/A
Completed NCT03736096 - Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients
Completed NCT03189537 - Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections Phase 3
Completed NCT03028077 - Effects of GS-3K8 and GINst15 on Acute Respiratory Illness N/A
Enrolling by invitation NCT01286285 - Surveillance of Influenza in Paediatric Intensive Care Units in Bavaria N/A
Completed NCT03840135 - Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI Phase 3
Completed NCT01488435 - Efficacy and Tolerance of a Follow-On Formula Fed to Children From 36-48 Months of Age N/A
Not yet recruiting NCT00545961 - Middle Meatal Bacteriology During Acute Respiratory Infection in Children Phase 4
Completed NCT05273619 - Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection Phase 3
Recruiting NCT04415827 - Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases N/A
Completed NCT03459391 - Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers Phase 1
Withdrawn NCT04938323 - Prevention of Acute Respiratory Infection in Taiwanese Institutionalized Elderly Phase 2/Phase 3
Completed NCT01693380 - Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza Phase 4